UBE2H (NM_003344) Human Tagged ORF Clone Lentiviral Particle

SKU RC202516L2V

Lenti ORF particles, UBE2H (mGFP-tagged) - Human ubiquitin-conjugating enzyme E2H (UBE2H), transcript variant 1, 200ul, >10^7 TU/mL

Product Data

• Type: Human Tagged ORF Clone Lentiviral Particle
• Tag: mGFP
• Target Symbol: UBE2H
• Synonyms: E2-20K; GID3; UBC8; UBCH; UBCH2
• Vector: pLenti-C-mGFP
• Mammalian Cell Selection: None
• Sequence Data:
  ORF Nucleotide Sequence

  The ORF insert of this clone is exactly the same as(RC202516).
• ACCN: NM_003344
• ORF Size: 549 bp
• OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
• OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
• Shipping: Dry Ice

Reference Data

• RefSeq: NM_003344.2
• RefSeq Size: 5174 bp
• RefSeq ORF: 552 bp
• Locus ID: 7328
• UniProt ID: P62256
• Cytogenetics: 7q32.2
• Domains: UBCc
• Protein Pathways: Ubiquitin mediated proteolysis
• MW: 20.7 kDa
• Summary: The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein sequence is 100% identical to the mouse homolog and 98% identical to the frog and zebrafish homologs. Three alternatively spliced transcript variants have been found for this gene and they encode distinct isoforms. [provided by RefSeq, Feb 2011]